1,540
Views
7
CrossRef citations to date
0
Altmetric
Research Articles

PLGA-modified Syloid®-based microparticles for the ocular delivery of terconazole: in-vitro and in-vivo investigations

, , &
Pages 2117-2129 | Received 16 May 2022, Accepted 13 Jun 2022, Published online: 15 Jul 2022

References

  • Agnihotri SM, Vavia PR. (2009). Diclofenac-loaded biopolymeric nanosuspensions for ophthalmic application. Nanomedicine 5:90–5.
  • Arpagaus C. (2012). A novel laboratory-scale spray dryer to produce nanoparticles. Drying Technol 30:1113–21.
  • Baydoun L, Furrer P, Gurny R, et al. (2004). New surface-active polymers for ophthalmic formulations: evaluation of ocular tolerance. Eur J Pharm Biopharm 58:169–75.
  • Bertram JP, Saluja SS, McKain J, et al. (2009). Sustained delivery of timolol maleate from poly (lactic-co-glycolic acid)/poly (lactic acid) microspheres for over 3 months. J Microencapsul 26:18–26.
  • Bouissou C, Rouse JJ, Price R, et al. (2006). The influence of surfactant on PLGA microsphere glass transition and water sorption: remodeling the surface morphology to attenuate the burst release. Pharm Res 23:1295–305.
  • Chaudhari SP, Gupte A. (2017). Mesoporous silica as a carrier for amorphous solid dispersion. BJPR 16:1–19.
  • Choudhari Y, Hoefer H, Libanati C, et al. (2014). Mesoporous silica drug delivery systems. In: Amorphous solid dispersions. Berlin: Springer, 665–693.
  • Ding D, Kundukad B, Somasundar A, et al. (2018). Design of mucoadhesive PLGA microparticles for ocular drug delivery. ACS Appl Bio Mater 1:561–71.
  • Donnadio A, Cardinali G, Latterini L, et al. (2019). Nanostructured zinc oxide on silica surface: preparation, physicochemical characterization and antimicrobial activity. Mater Sci Eng C 104:109977.
  • Dumitriu S, VI. Popa (2013). Polymeric biomaterials. Vol. 2. Florida, USA: CRC Press.
  • Foster CS. (1992). Fungal keratitis. Infect Dis Clin North Am 6:851–7.
  • Gaudana R, Ananthula HK, Parenky A, et al. (2010). Ocular drug delivery. Aaps J 12:348–60.
  • Gupta H, Aqil M, Khar RK, et al. (2010). Sparfloxacin-loaded PLGA nanoparticles for sustained ocular drug delivery. Nanomed Nanotechnol Biol Med 6:324–33.
  • Gupta H, Aqil M, Khar RK, et al. (2011). Biodegradable levofloxacin nanoparticles for sustained ocular drug delivery. J Drug Target 19:409–17.
  • Gupta N, Tandon R, Gupta SK, et al. (2013). Burden of corneal blindness in India. Indian J Community Med 38:198–206.
  • Heeres J, Hendrickx R, Van Cutsem J. (1983). Antimycotic azoles. 6. Synthesis and antifungal properties of terconazole, a novel triazole ketal. J Med Chem 26:611–3.
  • Huang W, Zhang C. (2018). Tuning the size of poly (lactic-co-glycolic acid)(PLGA) nanoparticles fabricated by nanoprecipitation. Biotechnol J 13:1700203.
  • Jaeger EA, Tasman W. (2009). Duane’s ophthalmology. Philadelphia, USA: Lippincott Williams & Wilkins.
  • Jain RA. (2000). The manufacturing techniques of various drug loaded biodegradable poly (lactide-co-glycolide)(PLGA) devices. Biomaterials 21:2475–90.
  • Kinnari P, Mäkilä E, Heikkilä T, et al. (2011). Comparison of mesoporous silicon and non-ordered mesoporous silica materials as drug carriers for itraconazole. Int J Pharm 414:148–56.
  • Konan YN, Gurny R, Allémann E. (2002). Preparation and characterization of sterile and freeze-dried sub-200 nm nanoparticles. Int J Pharm 233:239–52.
  • Limnell T, Santos HA, Mäkilä E, et al. (2011). Drug delivery formulations of ordered and nonordered mesoporous silica: comparison of three drug loading methods. J Pharm Sci 100:3294–306.
  • Maged A, Mahmoud AA, Ghorab MM. (2016). Nano spray drying technique as a novel approach to formulate stable econazole nitrate nanosuspension formulations for ocular use. Mol Pharm 13:2951–65.
  • Maged A, Mahmoud AA, Salah S, et al. (2020). Spray-dried rosuvastatin nanoparticles for promoting hair growth. AAPS PharmSciTech 21:1–12.
  • Mahmoud AA, Elkasabgy NA, Abdelkhalek AA. (2018). Design and characterization of emulsified spray dried alginate microparticles as a carrier for the dually acting drug roflumilast. Eur J Pharm Sci 122:64–76.
  • Makadia HK, Siegel SJ. (2011). Poly lactic-co-glycolic acid (PLGA) as biodegradable controlled drug delivery carrier. Polymers (Basel) 3:1377–97.
  • Mannermaa E, Vellonen K-S, Urtti A. (2006). Drug transport in corneal epithelium and blood–retina barrier: emerging role of transporters in ocular pharmacokinetics. Adv Drug Deliv Rev 58:1136–63.
  • Maulvi FA, Shetty KH, Desai DT, et al. (2021). Recent advances in ophthalmic preparations: ocular barriers, dosage forms and routes of administration. Int J Pharm 608:121105.
  • Mellaerts R, Roeffaers MBJ, Houthoofd K, et al. (2011). Molecular organization of hydrophobic molecules and co-adsorbed water in SBA-15 ordered mesoporous silica material. Phys Chem Chem Phys 13:2706–13.
  • Merkus HG. (2009). Particle size measurements: fundamentals, practice, quality. Vol. 17. Berlin, Germany: Springer Science & Business Media.
  • Mohsen AM. (2022). Cationic polymeric nanoparticles for improved ocular delivery and antimycotic activity of terconazole. J Pharm Sci 111:458–68.
  • Mu L, Feng S. (2003). A novel controlled release formulation for the anticancer drug paclitaxel (Taxol®): PLGA nanoparticles containing vitamin E TPGS. J Controlled Release 86:33–48.
  • Passerini N, Craig D. (2001). An investigation into the effects of residual water on the glass transition temperature of polylactide microspheres using modulated temperature DSC. J Control Release 73:111–5.
  • Patel A, Cholkar K, Agrahari V, et al. (2013). Ocular drug delivery systems: an overview. World J Pharmacol 2:47–64.
  • Patel VI, Dave RH. (2013). Evaluation of colloidal solid dispersions: physiochemical considerations and in vitro release profile. AAPS PharmSciTech 14:620–8.
  • Ruffel L, Soulié J, Coppel Y, et al. (2020). Ibuprofen loading into mesoporous silica nanoparticles using co-spray drying: a multi-scale study. Microporous Mesoporous Mater 291:109689.
  • Ruhe PQ, Hedberg EL, Padron NT, et al. (2003). rhBMP-2 release from injectable poly (DL-lactic-co-glycolic acid)/calcium-phosphate cement composites. JBJS 85:75–81.,
  • Sansone F, Mencherini T, Picerno P, et al. (2011). Maltodextrin/pectin microparticles by spray drying as carrier for nutraceutical extracts. J Food Eng 105:468–76.
  • Schmid K, Arpagaus C, Friess W. (2011). Evaluation of the Nano Spray Dryer B-90 for pharmaceutical applications. Pharm Dev Technol 16:287–94.
  • Shamma RN, Elkasabgy NA, Mahmoud AA, et al. (2017). Design of novel injectable in-situ forming scaffolds for non-surgical treatment of periapical lesions: in-vitro and in-vivo evaluation. Int J Pharm 521:306–17.
  • Sun Y, Huffman K, Freeman WR, et al. (2020). Intravitreal safety profiles of sol-gel mesoporous silica microparticles and the degradation product (Si (OH) 4). Drug Deliv 27:703–11.
  • Takeuchi H, Handa T, Kawashima Y. (1987). Spherical solid dispersion containing amorphous tolbutamide embedded in enteric coating polymers or colloidal silica prepared by spray-drying technique. Chem Pharm Bull (Tokyo) 35:3800–6.
  • Takeuchi H, Nagira S, Yamamoto H, et al. (2004). Solid dispersion particles of tolbutamide prepared with fine silica particles by the spray-drying method. Powder Technol 141:187–95.
  • Vogt M, Kunath K, Dressman JB. (2008). Dissolution enhancement of fenofibrate by micronization, cogrinding and spray-drying: comparison with commercial preparations. Eur J Pharm Biopharm 68:283–8.
  • Wang Y, Qin B, Xia G, et al. (2021). FDA’s poly (lactic-co-glycolic acid) research program and regulatory outcomes. Aaps J 23:1–7.
  • Xu W, Riikonen J, Lehto V-P. (2013). Mesoporous systems for poorly soluble drugs. Int J Pharm 453:181–97.
  • Youshia J, Ali ME, Lamprecht A. (2017). Artificial neural network based particle size prediction of polymeric nanoparticles. Eur J Pharm Biopharm 119:333–42.
  • Zaghloul N, El Hoffy NM, Mahmoud AA, et al. (2022). Cyclodextrin stabilized freeze-dried silica/chitosan nanoparticles for improved terconazole ocular bioavailability. Pharmaceutics 14:470.